Bridget Montgomery’s introduction to type 1 diabetes was when her son, Clifford, was diagnosed in DKA at the age of 6. It was at their initial type 1 diabetes training through Children’s Hospital of Pittsburgh that she learned about the opportunity to participate in TrialNet.

Elliot, a 17-year-old from a small village outside Bristol, recently completed treatment in the Abatacept Prevention Study. He is the first person in the United Kingdom (UK) to do so.

For the Loving family, knowledge is power, and they are forever grateful for TrialNet.